Skip to content

ECM

Eye Health News

  • Home
  • Conjunctivitis
  • Glaucoma
  • Cataract Surgery
  • Blog
VSP Vision Unveils ‘Practice of the Future’ Report, Exploring AI, Emerging Tech and New Care Models in Eyecare RANCHO CORDOVA, Calif.—The VSP Global Innovation Center (GIC) today released “Practice of the Future,” a new Futurist Report designed to explore how emerging technologies, artificial intelligence (AI) and new care models are becoming available to eyecare providers to meet growing patient demand, improve efficiency and expand their role within the broader healthcare ecosystem. The interactive…EYECAREAug 14 2026
Vuzix Posts Q2 Results, Looks to Opportunities in Enterprise Smart Glasses Markets ROCHESTER, N.Y—Vuzix Corporation (NASDAQ: VUZI), a leading supplier of AI-powered smart glasses, waveguides, and augmented reality (AR) technologies, yesterday announced its second quarter 2026 financial results.EYECAREAug 14 2026
Lensar Returns to Profit in Q2 on Strong Demand for ALLY Cataract System ORLANDO, Fla.—Lensar, Inc. (Nasdaq: LNSR), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, announced financial results for the quarter ended June 30, 2026, and provided an update on key operational initiatives.EYECAREAug 14 2026
California State University Institute Offered Practical Solutions for Sustainability During the FIFA World Cup LONG BEACH, Calif.—Sustainability and the World Cup are not necessarily contradictory concepts, according to Sheila Lakshmi Steinberg, director of California State University, Northridge’s (CSUN) Institute for Sustainability. Having attended the recent FIFA World Cup 2026 tournament did not mean attendees had to sacrifice their dreams of championing sustainability, Steinberg said. For the World Cup tournament,…EYECAREAug 13 2026
More Than 24,000 Cyclosporiasis Infections Reported as New Cases Appear to Slow: CDC Cases of cyclosporiasis have topped 24,000, according to the most recent data from the Centers for Disease Control and Prevention (CDC). There are at least 13,895 laboratory-confirmed cases of cyclosporiasis, including 740 hospitalizations, the data shows. The agency is also aware of at least 10,455 additional cases that have not yet been laboratory confirmed.EYECAREAug 13 2026
Stopping Statins in Trial Didn't Raise Mortality Risk, But ... Experts were still unsure whether stopping primary prevention statins in the elderly was a good idea following the report of a modestly sized randomized trial.EYECAREAug 13 2026
National Vision Posts Revenue Increase, Stronger Profitability in Q2 ALPHARETTA, Ga.—National Vision Holdings, Inc. (NASDAQ: EYE), one of the largest optical retail companies in the U.S., yesterday reported its financial results for the second quarter and year-to-date ended July 4, 2026. Net revenue for the quarter increased 2.5 percent year-over-year to $498.8 million, driven by what the company said was new store sales, a…EYECAREAug 13 2026
STAAR Surgical Q2 Sales Surge, Fueled by China as Key Market LAKE FOREST, Calif.—STAAR Surgical Company (NASDAQ: STAA), a global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, yesterday released financial results for the second quarter ended July 3, 2026.EYECAREAug 13 2026
Kalaris Therapeutics Reports Q2 Financial Results, Advances Clinical Program BERKELEY HEIGHTS, N.J.—Kalaris Therapeutics, Inc. (Nasdaq: KLRS), a clinical stage biopharmaceutical company, has announced financial results for the second quarter ended June 30, 2026, and provided business updates.EYECAREAug 13 2026
Don’t Overlook Your Child’s Vision This Back‑to‑School Season As families across Canada prepare for the new school year, the Canadian Ophthalmological Society (COS) is reminding parents that school supplies aren’t the only thing worth checking off the list. Good vision plays a critical role in learning, yet many childhood eye conditions can go unnoticed because children often don’t realize they’re having trouble seeing.EYECAREAug 12 2026
More Employers Are Dropping the Largest Pharmacy Benefit Managers More corporations are cutting ties with the three biggest pharmacy benefit managers and striking deals with smaller rivals to help manage their drug costs, a new survey from the National Alliance of Healthcare Purchaser Coalitions found.EYECAREAug 12 2026
One Broken Pathway Drives Aging. Scientists Aim to Fix It Every cell in the human body has a mini recycling crew. Its job is to hunt down damaged proteins, escort them to a recycling center (lysosome), and thread them one at a time through a molecular pore for destruction. The process is called chaperone-mediated autophagy (CMA), and it happens in every tissue, every day. Until…EYECAREAug 12 2026
Alcon Q2 Sales Rise on Strength in Vision Care, Surgical SegmentsGENEVA—Global eyecare leader Alcon (SIX/NYSE:ALC) reported its financial results for the second quarter and the half, marking the three- and six-month periods, respectively, ending June 30, 2026. For the second quarter of 2026, Alcon reported net sales reached $2.8 billion, marking an 8 percent increase, or 7 percent on a constant currency basis, over the…EYECAREAug 12 2026
Lenz Therapeutics Posts Q2 Revenue Fueled by VIZZ Sales and License AgreementsSAN DIEGO—Lenz Therapeutics, Inc. (Nasdaq: LENZ), a pharmaceutical company, yesterday reported financial results for the second quarter ended June 30, 2026. Total revenue for the second quarter was $5.5 million from VIZZ product sales and license agreements.EYECAREAug 12 2026
NECO Opens Registration for 2026 Industry Collaborative With Keynote Speaker John Della VolpeBOSTON—New England College of Optometry (NECO) has opened registration for its 2026 Industry Collaborative “Traversing the Shift: Critical Thinking & Patient-Centered Care in an Era of Emerging Technology,” scheduled for November 5 and 6, 2026.EYECAREAug 12 2026
AI in Eye Care: The AI Imposter in Our InboxWe are currently navigating a strange new landscape in digital eyecare. It’s a stage where bad actors use generative technology to flood social media platforms with content that masquerades as professional expertise. I’m not talking about misguided amateur influencers; I’m talking about completely fabricated digital entities posing as ophthalmologists. I recently stumbled upon a YouTube…EYECAREAug 11 2026
Women Who Are Postmenopausal Exhibit More Severe Dry Eye DiseaseDry eye disease (DED) becomes more severe after menopause, driven by tear film instability and meibomian gland dysfunction (MGD), according to results of a cross-sectional study published in Post Reproductive Health. Women are more likely to develop DED in later life and prior studies have reported that women who are postmenopausal present with more severe…EYECAREAug 11 2026
Testing Is Underway on Vaccines to Intercept Brewing Colon Cancer Before It Takes RootDr. Stacy Norton was only 7 years old when her mother died of colon cancer, one of several family members struck by aggressive tumors at unusually young ages. Decades later, Norton rolled up her sleeve to help test if a new kind of vaccine might protect her and her own children from cancer.EYECAREAug 11 2026
Together, Two Everyday Health Factors Double Death Risk in Midlife and BeyondTwo factors dramatically increase the risk of early death for middle-aged folks and seniors, a new study says—belly fat and vitamin D deficiency. People over 50 with belly fat and low vitamin D have a more than doubled risk of death, compared to folks without those conditions, researchers reported recently in the journal Diabetes, Obesity…EYECAREAug 11 2026
Harrow Achieves Q2 Revenue Growth, Reiterates 2026 Full-Year Financial GuidanceNASHVILLE, Tenn.—Harrow (Nasdaq: HROW), a provider of ophthalmic disease management solutions in North America, yesterday announced financial results for the second quarter ended June 30, 2026. The company delivered Q2 revenue of $70.7 million, an increase of 60 percent sequentially, and 11 percent year over year. GAAP net loss for the second quarter of 2026…EYECAREAug 11 2026
Oculis Announces Asset Purchase Agreement With Accure Therapeutics, Posts Q2 2026 Financial ResultsZUG, Switzerland—Oculis Holding AG (Nasdaq: OCS / XICE: OCS), a global biopharmaceutical company, has announced an asset purchase agreement with Accure Therapeutics, a clinical-stage, R&D-driven biopharmaceutical company.EYECAREAug 11 2026
SpyGlass Pharma Reports Q2 Financials, Provides Corporate UpdatesIRVINE, Calif.—SpyGlass Pharma, Inc. (Nasdaq: SGP) reported financial results for the second quarter ended June 30, 2026, and provided a corporate update. The company experienced a net loss of $19.9 million for the quarter.EYECAREAug 11 2026
Meta Offers Small Business Owners a ‘Playbook’ for the HolidaysSAN MATEO, Calif.—Meta has introduced the Meta Holiday Insights Center, a free hub that can help small businesses understand how their customers plan to shop this peak season based on insights from more than 14,000 holiday shoppers. The company is also sharing examples of how real small businesses are already using Meta's tools to reach…EYECAREAug 10 2026
Health Officials Urge Caution for Gulf Coast Beachgoers During Surge of Deadly Bacterial InfectionsHealth officials in Louisiana are urging beachgoers to take precautions during a summertime surge in infections from a flesh-eating bacteria found in coastal waters. Louisiana has confirmed nine cases of Vibrio vulnificus infections this year, the state's health department said last week in a news release. All were hospitalized, and five died.EYECAREAug 10 2026
Donor Hearts May Work Better If Stored Slightly WarmerColder was not better when it came to donor heart storage, according to preliminary findings from a retrospective analysis. Between static cold storage (SCS) at 4-8°C and 10°C, there was a marked difference in outcomes across adult heart transplants performed at two high-volume centers in the U.S., reported a team led by Aaron Williams, MD,…EYECAREAug 10 2026
iCare, EyeCheq Partner to Expand Point-of-Care Eye Screening in U.S.MIAMI, Fla. and VANTAA, Finland—iCare, part of global health tech company Revenio Group, (REG1V: Nasdaq Helsinki) has entered into a partnership agreement and strategic minority investment with U.S.-based eye health company EyeCheq, the companies announced. The move aims to expand access to point-of-care eye screening through the deployment of EyeCheq stations in the U.S., the…EYECAREAug 10 2026
Bausch + Lomb Updates Board, Reaffirms 2026 GuidanceVAUGHAN, Ontario.—Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, has announced changes to its board of directors and reaffirmed its 2026 full-year guidance, which it raised on July 29, 2026.EYECAREAug 10 2026
SUNY College of Optometry Foundation to Host Inaugural Advancing Vision Summit on September 25NEW YORK—SUNY College of Optometry Foundation announced it will host the inaugural Advancing Vision Summit: The Intersection of AI, Eye Care, and Public Health on September 25, 2026, at CURE in New York City.EYECAREAug 10 2026
RxSight Reports Q2 Financial Results, Provides Update on 2026 OutlookALISO VIEJO, Calif.—RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company, has reported financial results for the quarter ended June 30, 2026, and provided an update on its 2026 financial outlook.EYECAREAug 10 2026
CDC Adds Almost 100 New Cases to Expanding U.S. Measles OutbreakThe Centers for Disease Control and Prevention (CDC) confirmed 94 new measles infections—most of them in Pennsylvania—bringing the U.S. total for the year to 2,465, the agency said in its weekly update. The numbers likely provide additional data to move the United States toward losing its measles elimination status this year. The nation gained that…EYECAREAug 07 2026
What to Know About the Multistate Salmonella Outbreak in the U.S.U.S. health authorities are currently investigating a multistate outbreak of salmonella javiana infections linked to fresh jalapeno peppers. The investigation is being carried out jointly by the Centers for Disease Control and Prevention and the U.S. ⁠Food and Drug Administration, alongside state and local health departments.EYECAREAug 07 2026
Warby Parker Q2 Revenue Rises as Launch of Intelligent Eyewear NearsNEW YORK—Warby Parker Inc. (NYSE: WRBY) announced earnings yesterday for the second quarter, demonstrating revenue growth of 9.8 percent while also teasing the upcoming launch of the lifestyle brand’s first-ever intelligent eyewear collection. In addition to sharing the $21.0 million rise in net revenue, bringing total revenue for the quarter to $235.5 million, the company…EYECAREAug 07 2026
Tarsus to Acquire Alkeus in $450 Million Deal, Reports Strong Quarter and HalfIRVINE, Calif.—Tarsus Pharmaceuticals announced yesterday that it has entered into a definitive agreement to acquire Alkeus Pharmaceuticals, Inc., a privately held retinal disease-focused biotechnology company developing gildeuretinol (ALK-001).EYECAREAug 07 2026
Harrow Enters Agreement to Acquire Tyrvaya Dry Eye Treatment From Viatris Inc.NASHVILLE, Tenn.—Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, announced that it has entered into a definitive agreement to acquire Tyrvaya (varenicline solution) from Viatris Inc.EYECAREAug 07 2026
The Critical Role of Empathy and Compassion in Patient CareWith technology evolving at a rapid pace and time in the exam lane at a premium, ODs and practice owners can easily underestimate the importance of patient empathy and compassion as crucial "soft skills." In optometry, patient empathy refers to the capacity to comprehend and connect with a patient's emotional journey concerning their vision care.…EYECAREAug 06 2026
Why Omnichannel Marketing Is Turning Into a ‘Must-Have’ for Optometry PracticesOmnichannel marketing can offer some key advantages for optometrists and optical retailers, such as enhanced patient engagement, consistent messaging across platforms, and heightened brand awareness. As personalized care and meeting patients where they are becomes increasingly essential for eyecare professionals, this strategy seamlessly unifies patient touchpoints—including search engines, social media, text messages, email, and the…EYECAREAug 06 2026
U.S. FDA Approves First mRNA Flu Shot From ModernaThe U.S. Food and Drug Administration has approved Moderna's flu vaccine for people aged 50 and older, the company said on Wednesday, marking the first approval ‌of a messenger RNA-based vaccine for seasonal flu. The shot, mFlusiva, was given a traditional approval ‌for adults aged 50 to 64, and an accelerated approval for those 65…EYECAREAug 06 2026
Avoiding 3 Things During Middle Age May Delay Dementia Risk by 13 YearsAvoiding three health factors may delay the odds of developing dementia by about 13 years, a new study has found: type 2 diabetes, smoking and high blood pressure. Scientific research has long established that these risk factors are three of the strongest for dementia, and that the neurodegenerative disease’s development begins long before symptoms arrive,…EYECAREAug 06 2026
Kits Eyecare Posts Strong Q2 Revenue, Driven by Surge in Glasses SalesVANCOUVER, British Columbia—Kits Eyecare Ltd. (TSX: KITS), a leading vertically integrated eyecare provider, yesterday announced its financial results for the second quarter ended June 30, 2026. Revenue for the period increased by 17.8 percent versus Q2 2025 to reach $58.4 million (CAD), the company said, led by glasses revenue that grew 54.0 percent and now…EYECAREAug 06 2026
As Wildfires Burn, Eye Health Is a Key ConcernNEWARK, N.J.—Wildfires and other natural disasters continue to wreak havoc this summer. While firefighters work to protect life and property, another concern has arisen, with eye health and vision care emerging as a key area impacted by these natural disasters.EYECAREAug 06 2026
As Wildfires Burn, Eye Health Is a Key ConcernNEWARK, N.J.—Wildfires and other natural disasters continue to wreak havoc this summer. While firefighters work to protect life and property, another concern has arisen, with eye health and vision care emerging as a key area impacted by these natural disasters.EYECAREAug 06 2026
Sight Sciences Sees Q2 Revenue Growth, Raises 2026 GuidanceMENLO PARK, Calif.—Sight Sciences, Inc. (Nasdaq: SGHT) reported financial results yesterday for the second quarter ended June 30, 2026, while raising its revenue guidance and reducing its adjusted operating expense guidance for full year 2026.EYECAREAug 06 2026
EyePoint Reports Q2 2026 Financial Results and Highlights Recent Corporate DevelopmentsWATERTOWN, Mass.—EyePoint, Inc. (Nasdaq: EYPT), a clinical-stage biopharmaceutical company, announced financial results for the second quarter ended June 30, 2026, and highlighted recent corporate developments.EYECAREAug 06 2026
What Is Rabbit Fever? Cases of Rare Tick-Borne Illness Reported in NYCHealth officials in New York are warning residents about a rare tick-borne illness after three cases were reported on Long Island. Three people in Suffolk County were confirmed to have come down with tularemia, also known as rabbit fever. The disease can cause high fevers and extreme fatigue, and doctors say symptoms can be more…EYECAREAug 05 2026
Blood Pressure Variability Linked to Cognitive Decline in High-Risk AdultsHigher visit-to-visit systolic blood pressure (BP) variability was independently associated with faster cognitive decline in adults at elevated cardiovascular risk, regardless of mean BP levels in a study. Researchers conducted a pooled individual-participant analysis including 11,104 participants from two randomized controlled trials: the SPRINT-MIND (n = 9,361; hypertensive adults without diabetes) and ACCORD-MIND (n =…EYECAREAug 05 2026
Warren Foust Named President and CEO of STAAR Surgical, Deborah Andrews Transitions to Executive Vice President and CFO RolesLAKE FOREST, Calif.—STAAR Surgical Company (NASDAQ: STAA), a global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, has announced that its board of directors has appointed Warren Foust as president, chief executive officer and a new member of the Board, effective August 4, 2026. Foust joined…EYECAREAug 05 2026
Safilo Group Reports Q2 and Half Year 2026 Financial ResultsPADUA, Italy—Safilo Group reported financial results yesterday for the second quarter and first-half of 2026. Net sales in the second quarter were €239.1 million, down 4.5 percent at constant exchange rates and 5.1 percent at current exchange rates year-over-year. The company closed the first half of 2026 with net sales of €512.0 million, down 1.9…EYECAREAug 05 2026
Bascom Palmer Eye Institute Ranked Nation's No. 1 in Ophthalmology by U.S. News & World ReportMIAMI—Bascom Palmer Eye Institute of the University of Miami Health System announced it has again been ranked as the nation’s best in ophthalmology by U.S News & World Report. This year marks the 25th time that Bascom Palmer has received the No. 1 ranking.EYECAREAug 05 2026
Treatment Trials for Ebola Strain Behind Congo Outbreak Show Promise, WHO SaysTesting of experimental treatments, preventive medicines and vaccines for the Bundibugyo strain of Ebola behind Democratic Republic of Congo's ongoing outbreak is advancing rapidly, the U.N.'s World Health Organization said on Tuesday. The epidemic—the second-largest and fastest-spreading on record—was caused by the rare Bundibugyo strain of the virus, for which there are no approved vaccines…EYECAREAug 04 2026
Doctor Warns Against ‘Cyclospora Skinny’ TrendAn outbreak of the disease-causing parasite cyclospora has infected thousands of Americans from coast to coast and has given rise to a dangerous trend called “cyclospora skinny." What began as a joke about the infection symptoms like weight loss and low appetite is now prompting warnings from health professionals.EYECAREAug 04 2026
VSP Vision Names Roheena Malik, OD, as Inaugural Recipient of the Dr. Stephanie Kirschbaum Living in Purpose AwardRANCHO CORDOVA, Calif.—VSP Vision announced that Roheena Malik, OD, a VSP network optometrist and 2025 VSP Future Leaders Academy graduate, has been selected as the first recipient of the Dr. Stephanie Kirschbaum Living in Purpose Award. Established in honor of Dr. Stephanie Kirschbaum—a longtime VSP network optometrist, California VSP ambassador, and VSP Eyes of Hope…EYECAREAug 04 2026
With Appointment of Darline Graham Nordone, an Optician Heads to the SenateWASHINGTON, D.C.—Following the death of Sen. Lindsey Graham of South Carolina in July, his sister, Darline Graham Nordone, also of South Carolina, was appointed to finish his term.  As reported in 20/20 magazine’s latest edition of Pro to Pro, the appointment marks a significant milestone for the vision care industry, as all “three Os”—ophthalmology, optometry…EYECAREAug 04 2026
Ocular Therapeutix Reports Second Quarter Revenue, Provides Business HighlightsBEDFORD, Mass.—Ocular Therapeutix, Inc. (NASDAQ: OCUL), an integrated biopharmaceutical company in the retina space, has reported financial results for the second quarter ended June 30, 2026, and provided recent business highlights.EYECAREAug 04 2026
Aravind Eye Care System and Alcon Launch Global Retina Surgery Training CentreCOIMBATORE, India—Aravind Eye Care System, a network of eye hospitals and clinics based in Tamil Nadu, India, and Alcon have launched the Aravind Alcon Global Centre of Excellence (CoE) for Vitreoretinal Surgery Training in Coimbatore.EYECAREAug 04 2026
Orbis International Forms Partnership With AirAsia Group to Expand Eyecare Access Across Asia-Pacific RegionNEW YORK—Orbis International and AirAsia Group (formerly known as AirAsia X Berhad) have announced a partnership in which AirAsia will provide $100,000 in air fare support annually over the next five years.EYECAREAug 04 2026
Bridging the Divide: How Teleoptometry Is Transforming Care in ‘Healthcare Deserts’Healthcare deserts—areas without adequate infrastructure or access to medical services—now exist in approximately 80 percent of U.S. counties and affect roughly one in three Americans, according to a 2025 report from GoodRx Health, an online health information resource. Since 2021, these regions have seen an expansion in pharmacy deserts, the report noted, while access to…EYECAREAug 03 2026
First Deaths Reported in Cyclosporiasis OutbreakTwo people in Michigan have died in connection with the outbreak of cyclosporiasis, health officials reported Monday. These are the first known deaths related to the multi-state outbreak of explosive diarrhea in the United States.EYECAREAug 03 2026
Colorectal Cancer Is on the Rise—and Often Overlooked—in This Surprising GroupData from Australia suggests cases of pregnancy-associated colorectal cancer (which arise during pregnancy or in the first year postpartum) have increased by about 6 percent each year from 1994 to 2013. There’s no evidence that pregnancy itself increases susceptibility, said Marwan Fakih, division chief of GI medical oncology at cancer center City of Hope. And…EYECAREAug 03 2026
Redefining Obesity: The Push to Move Beyond BMIBody mass index (BMI) has long been the standard for diagnosing obesity. A BMI of 25 to less than 30 is considered overweight, while a BMI of 30 or higher defines obesity. However, momentum is building to move beyond BMI.EYECAREAug 03 2026
Hoya Posts Record 16 Percent Revenue Growth in 2026 First Quarter, Eyeglass Lens Sales IncreaseTOKYO—Hoya Corporation (7741:Tokyo) reported record revenue growth for the three months ended June 30, 2026, with revenue increasing 16.0 percent year-over-year to 255.7 billion yen and profit for the first quarter climbing 28.1 percent to 65.8 billion yen. The revenue increase was driven by strong performance in both the company’s Life Care segment, which includes…EYECAREAug 03 2026
Prime Ministerial Vision Initiative Launches in Antigua and Barbuda to Advance National Eye HealthST. JOHN’S, Antigua and Barbuda—The government of Antigua and Barbuda, in partnership with global nonprofits RestoringVision, Cure Blindness Project and VisionSpring, announced it has officially launched the Prime Ministerial Vision Initiative on July 30.EYECAREAug 03 2026
Urvi Patel, UAB School of Optometry Student, Appointed to AOSA Executive Council Board of TrusteesBIRMINGHAM, Ala.—The University of Alabama at Birmingham’s (UAB) School of Optometry has announced that Urvi Patel, class of 2028, was elected as a trustee of the American Optometric Student Association’s (AOSA) Executive Board.EYECAREAug 03 2026
Review of Myopia Management Announces Speakers and CE Courses for Its Full-Day Myopia Management Live Event in Irving, TexasIRVING, Texas—Review of Myopia Management (RMM) has announced a live, full-day event on August 30, 2026, at the OMNI Las Colinas Hotel, Irving, Texas, designed to help ECPs implement or strengthen their myopia management programs.EYECAREAug 03 2026
The Science Behind Social Media's 'Early Bird Dinner': How Early Dining May Impact Sleep and WeightA social media trend urging people to finish dinner by 5 p.m. is getting a second look from doctors, after a randomized trial found that adults who confined their eating to an eight-hour daily window for 12 weeks kept off several more pounds a full year later, compared to those who ate on a normal…EYECAREJul 31 2026
Africa CDC Chief Says ‘No Magical Solution’ for Intensifying Deadly Ebola OutbreakThe Ebola outbreak in the Democratic Republic of Congo (DRC) continues to move faster than the response amid “intense” community transmission, with government officials announcing the death toll has surpassed 1,500. In an update on July 30, the Congolese government said 3,442 cases have been reported, with 1,521 deaths, according to the Associated Press.EYECAREJul 31 2026
When Temperatures Climb, Hypoglycemia Risk Rises in Type 1 DiabetesRising temperatures appear to significantly increase the short-term risk for hypoglycemia among adults with type 1 diabetes (T1D), new research suggested. An analysis of more than 32 million continuous glucose monitor (CGM) readings from nearly 700 adults with T1D in the UK showed a 26 percent greater risk for hypoglycemia at a temperature of 25…EYECAREJul 31 2026
Patients Who Wear Soft Contact Lenses Are Significantly More Profitable Than Glasses-Only Wearers, Study Commissioned by CLI FindsWASHINGTON, D.C.—A new study from a team of ophthalmic and economics researchers has shown that patients who wear soft contact lens create a sizable practice profitability advantage compared with equivalent glasses-only patient wearers. The upside ranges from 29 percent to 86 percent annually, with substantial potential gains over a lifetime of wear, the study revealed.…EYECAREJul 31 2026
Optometry Giving Sight Launches 2026 World Sight Day Challenge, Marks 20th Anniversary of EventGOLDEN, Colo., and CALGARY, Alberta—Optometry Giving Sight (OGS) has announced the launch of the 2026 World Sight Day Challenge (WSDC), its annual fundraising campaign that brings together optometry practices, optometry schools, industry partners and supporters across North America and beyond to raise funds for sustainable vision care programs worldwide. This year marks the 20th anniversary…EYECAREJul 31 2026
Foundation Fighting Blindness Urges Withdrawal of New Federal Funding Rule to Prioritize Patient HealthCOLUMBIA, Md.—The Foundation Fighting Blindness is urging the Office of Management and Budget (OMB) to withdraw its proposed rule (docket OMB-2026-0034) titled Regulation for Federal Financial Assistance.EYECAREJul 31 2026
Women In Optometry Honors Six ODs as 2026 Theia Award WinnersNEWARK, N.J.—Women In Optometry (WO) has named six optometrists as 2026 Theia Award recipients. The awards are presented annually to women who have made exceptional contributions to optometry across a variety of professional roles.EYECAREJul 31 2026
PDS Optical Hits Milestone With 1 Million Pairs of Prescription Eyeglasses Shipped to U.S. VeteransLOUISVILLE, Ky.—PDS Optical, a provider of prescription eyeglasses to U.S. veterans, announced that it has shipped its one-millionth pair of prescription eyeglasses to the nation’s veterans this year. PDS Optical has served U.S. veterans for more than 25 years.EYECAREJul 31 2026
TIME and Statista Rank 2026’s Most Sustainable Companies, Including Fashion and Optical BrandsNEW YORK—TIME and Statista recently published their list of the World’s Most Sustainable Companies for 2026. The list includes 750 companies spread across more than 40 countries, with the U.S., United Kingdom, and Japan hosting the highest numbers. Several fashion and luxury brands are featured prominently, as well as a major optical company, underscoring the…EYECAREJul 30 2026
Mitsui Chemicals Vision Care Materials Relaunches Expanded ‘Do Green’ Sustainability PlatformTOKYO—Mitsui Chemicals’ Vision Care Materials Division has relaunched the “Do Green” platform expanding its scope beyond bio-based lens materials to address environmental impact across the eyeglass lens life cycle, the company said in an announcement. Do Green was originally introduced as a label for eco-friendly ophthalmic lens materials and now encompasses material innovation, manufacturing, carbon…EYECAREJul 30 2026
Jetting Off for a Summer Vacation? How to Eat and Drink to Minimize Jet LagJet lag threatens to turn even a dream vacation into a slog. And with peak travel season underway, millions of people may have to contend with this disorienting condition, which can cause sleep disturbances, daytime tiredness, headaches and nasty gastrointestinal symptoms.EYECAREJul 30 2026
American Red Cross Declares Second-Ever National Blood Supply Crisis, Urges Immediate Blood DonationsThe American Red Cross has declared only the second national blood supply crisis in its history after blood donations fell to a four-year summer low, deepening an emergency shortage that threatens the availability of lifesaving blood for patients across the country. Despite thousands of people answering the call to give, blood donations are not keeping…EYECAREJul 30 2026
Premium IOLs Help Propel Strong Q2 as Bausch + Lomb Reports Growth and Raises 2026 GuidanceVAUGHAN, Ontario—Global eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO) yesterday announced its second quarter 2026 financial results and updated its 2026 full-year guidance. Total reported revenue was $1.394 billion for the second quarter of 2026, compared with $1.278 billion in the second quarter of 2025, an increase of $116 million, or 9 percent.…EYECAREJul 30 2026
Five Optometry Students Receive Dr. Marvin R. Poston Leadership Award From VSP VisionRANCHO CORDOVA, Calif.—VSP Vision has named five optometry students as recipients of the 2026 Dr. Marvin R. Poston Leadership Award, presented in partnership with the National Optometric Association (NOA), according to an announcement.EYECAREJul 30 2026
The Vision Council Highlights Latest Tariff Impacts on Optical IndustryALEXANDRIA, Va.—In response to the latest round of tariffs that went into effect last week, The Vision Council announced it is helping members navigate yet another shift in U.S. trade policy.EYECAREJul 30 2026
The Frame Affair Named as Exclusive U.S. Distributor for Valley EyewearQUEENSLAND, Australia—Independent premium eyewear brand Valley Eyewear, announced it has named The Frame Affair as its exclusive U.S. distribution agency, marking what the brand said is a significant step in its global optical boutique expansion strategy. As the exclusive distributor, The Frame Affair, which is a combined distribution agency and trade show, will oversee brand…EYECAREJul 30 2026
40 Percent of Americans Are Buying Fewer Fruits and Vegetables During Cyclospora OutbreakRoughly 40 percent of Americans are eating or buying less fresh fruit and vegetables due to nationwide outbreaks of a foodborne illness that leaves victims with explosive diarrhea, a new survey has found. Cyclosporiasis has sickened 16,000 people across over 40 states with Michigan experiencing more than 9,200 cases. At least 300 people have been…EYECAREJul 29 2026
The Future of Peptides in the U.S. Is About to Become Clearer. Here’s What You Should KnowA little-known advisory group to the US Food and Drug Administration met last week to mull over whether to ease restrictions on certain peptides. The injectables are popular among wellness influencers and some doctors, who say they improve muscle recovery, reduce inflammation, promote longevity or simply boost your overall health.EYECAREJul 29 2026
AI Smart Glasses and Myopia Management Portfolio Drive Q2 and First Half Revenue Growth for EssilorLuxotticaPARIS—EssilorLuxottica (Reuters: ESLX.PA) announced on Tuesday its second quarter and first-half 2026 financial results for the period ended June 30, 2026. During the initial six months of the year, revenue grew by 5.7 percent year-over-year to €14,818 million, representing a 9.7 percent increase at constant exchange rates with broad-based contributions from all business segments and…EYECAREJul 28 2026
Kentucky Tightens Optometry Licensing Rules, But Debate Continues Over Previously Licensed ODsLOUISVILLE, Ky.—The Kentucky Board of Optometric Examiners (KBOE) has filed an emergency amendment this month to restore full national testing requirements for new optometrists in this state. The latest turn in a broader dispute that dates to 2020-2023, the move attempts to remedy pandemic-era measures during which the state board granted waivers or alternative testing…EYECAREJul 28 2026
Inspecs Appoints Robert Brodie as New Chief Financial OfficerBATH, U.K.—Inspecs Group plc (LSE: SPEC), a global designer, manufacturer and distributor of eyewear that includes sunglasses, optical frames, lenses and low-vision products, has announced the appointment of Robert Brodie as its new chief financial officer. Brodie is expected to join the group in Fall 2026 and will also sit on the board as an…EYECAREJul 28 2026
The Vision Council Invites Members to Save the Date for 2027 Executive Summit in San AntonioALEXANDRIA, Va.—The Vision Council has announced that its 2027 Executive Summit will be held Wednesday, January 20 to Friday, January 22, at the La Cantera Resort & Spa in San Antonio, Texas. The Executive Summit, the group’s signature event, aims to illuminate the dynamic changes ahead for the vision community, the announcement said. With a…EYECAREJul 28 2026
Orbis Marks 30 Years of Advancing Eyecare in VietnamDA NANG, Vietnam—Orbis International is celebrating 30 years of partnership with Vietnam’s eye health community, a collaboration that has helped strengthen local eyecare capacity, expand access to services, and establish the country as a growing leader in eye health across the Asia-Pacific region.EYECAREJul 28 2026
Study Links GLP-1s to Lower Risk of Fragility Fractures in Diabetes PatientsStarting a GLP-1 receptor agonist for type 2 diabetes was associated with a lower risk of fragility fractures in adults 50 and older, including hip and vertebral fractures, according to a large target trial emulation study.EYECAREJul 27 2026
ADHD Looks Different in Women and Poses Unique Health RisksSchool used to be pretty easy for Kate Jarvis when she was a little girl, back in the 1980s. She was a straight-A student, creative, and so organized that she'd even prep her toothbrush with toothpaste each night before school. She says her mother used to call her "bright-eyed and bushy tailed."EYECAREJul 27 2026
Cyclospora Outbreaks Start With Human Contamination. Nobody Has Ever Been Able to Figure Out HowAs cases of explosive diarrhea continue to rise across the U.S. this summer, health officials are grappling with a long-standing question about the tiny parasite that’s behind all this torment: Just how the heck is poop getting into our food?EYECAREJul 27 2026
Optical Industry Braces for Impact as New Tariffs Add Pressure on Global Trade PartnersNEWARK, N.J.—As industry experts anticipated, President Trump on Thursday night issued a new swath of tariffs ranging between 10 percent to 12.5 percent on imports from 60 economies, citing alleged failures to enforce bans on goods produced with forced labor under Section 301 of the Trade Act of 1974. The new tariffs replace Section 122…EYECAREJul 27 2026
FDA Approves Outlook Therapeutics’ Lytenava to Treat Wet AMDISELIN, N.J.—Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of Lytenava (bevacizumab-vikg, bevacizumab gamma) for the treatment of retinal diseases, has announced its approval by the U.S. Food and Drug Administration (FDA) for the treatment of neovascular age-related macular degeneration (nAMD), commonly known as wet AMD. The approval now…EYECAREJul 27 2026
Prevent Blindness Expands Vision Advocacy, Declares August as Children’s Eye Health and Safety MonthCHICAGO—Prevent Blindness has declared August as Children’s Eye Health and Safety Month. Prevent Blindness noted that uncorrected vision disorders can impair child development, interfere with learning and even lead to permanent vision loss.EYECAREJul 27 2026
NORA Offers Student and Resident Grants to Attend Its Annual ConferenceLOUISVILLE, Ky.—The Neuro-Optometric Rehabilitation Association, International (NORA) is offering up to 10 students and residents with an interest in neurorehabilitation an opportunity to apply for a student grant to attend its 2026 annual conference.EYECAREJul 27 2026
Office-Based Surgery: A Path to Better Patient Care and Practice GrowthOffice-based surgery (OBS) continues to build new opportunities for eyecare providers (ECPs) as it creates more diverse patient care options and the potential for expanded practice revenue. A significant opportunity to grow profitability, OBS, done in partnership with qualified ophthalmic surgeons, can bring high-value services in-house that would traditionally be referred elsewhere. Last week, VMAIL Weekend…EYECAREJul 24 2026
10 Foods That Food Safety Experts Never EatAsk someone who investigates foodborne illness for a living what they won't put on their plate, and the list is shorter—and stranger—than you'd expect. It's not that these experts live in fear. Most will tell you that all food carries some risk, and the real skill is deciding which risks are worth taking.EYECAREJul 24 2026
Traffic Noise a Novel Parkinson’s Risk Factor?Long-term exposure to residential traffic noise was associated with a higher risk for Parkinson’s disease (PD), independent of air pollution, green space and socioeconomic factors, a large Danish study showed. However, this association may be mitigated by having a “quiet façade” that provides residents with a reprieve from excessive noise, researchers noted.EYECAREJul 24 2026
Accreditation Council on Optometric Education Reinforces Standards With Key ActionsPHOENIX—At its board meeting last month at Optometry’s Meeting 2026 in Phoenix, the Accreditation Council on Optometric Education (ACOE) made several accreditation actions and decisions based on these standards, according to an announcement.EYECAREJul 24 2026
United Ocular Announces the Acquisition of Glenn Reams OcularistMIDVALE, Utah—United Ocular, a medical practice dedicated to fitting, creating, and maintaining eye prostheses, has announced the acquisition of Glenn Reams Ocularist, an ocular prosthetics practice that has served patients for more than four decades.EYECAREJul 24 2026
Review of Ophthalmology: Current Approaches for Vitreous Floater TreatmentIn the past, retina specialists by and large avoided treating vitreous floaters for a variety of reasons. In recent years, however, some physicians have warmed to the idea of treating floaters in certain cases in which they’re visually significant. Here, physicians familiar with floater treatment discuss how to assess and select patients for treatment; describe…EYECAREJul 23 2026
How Community Outreach Helps Optometry Practices ThriveCommunity outreach offers significant advantages to optometry practice owners and staff, regardless of whether they are launching a practice in a new location or have served as a long-standing pillar of the local community. By building patient trust, community outreach fulfills the profession’s responsibility to expand vision care access for underserved populations. Additionally, it functions…EYECAREJul 23 2026
A Strategic Guide to Adopting New Optometric TechnologyTo remain competitive in a rapidly advancing tech-driven field, optometry practices must regularly implement system upgrades and new technologies. To ensure a smooth and efficient transition when integrating advanced tools like artificial intelligence or enhanced EHR systems for both staff and patients, careful planning and analysis are required. This can involve phased introductions, providing hands-on…EYECAREJul 23 2026
Scientists May Have Found a Natural Defense Against Aging. There’s a CatchA hormone that naturally declines as we grow older may play a key role in the chronic inflammation linked to cancer and other age-related diseases, according to new research in mice. The hormone, called thymulin, is produced by the thymus, a small organ behind the breastbone that helps train the body's immune system.EYECAREJul 23 2026
Women Have Worse Signs, Symptoms of Neurologic Long COVID Than Men, Researchers SayMore than a year after COVID-19 symptom onset, both previously hospitalized and nonhospitalized women who had long COVID reported four neurologic symptoms more often than their male peers, Northwestern University researchers write. For the study, published in the Annals of Clinical and Translational Neurology, the authors analyzed 261 hospitalized patients (PNP) and 2,068 nonhospitalized patients…EYECAREJul 23 2026
Tariffs Set to Expire July 24, But New Duties May Follow Quickly, Experts SayNEWARK, N.J.—The sweeping 10 percent tariffs imposed by President Trump early this year under Section 122 of the Trade Act of 1974 are set to expire this Friday, July 24, but White House officials and optical industry experts say they expect the tariffs to be replaced quickly. In addition, earlier this week, the administration also…EYECAREJul 23 2026
VSP Vision Surpasses $3 Million in Student Debt Relief for ODsRANCHO CORDOVA, Calif.—VSP Vision announced that it has provided more than $3 million in debt relief to 70 optometry students, recent graduates and practicing optometrists since the inception of the VSP Vision Student Loan Repayment Program in 2023.EYECAREJul 23 2026
The Vision Council Names Brandon Butler Recipient of the 2026 Goodfellow AwardALEXANDRIA, Va.—The Vision Council has named Brandon Butler the recipient of the 2026 Goodfellow Award, which recognizes an individual who has significantly contributed to the advancement of the optical industry.EYECAREJul 23 2026
Review of Myopia Management: The Biggest Pain Points in Myopia ManagementPediatric myopia care in the United States has undergone a significant transformation. “Over the past 12 years, pediatric myopia care in the United States has evolved from a primarily corrective model—relying on single-vision spectacles or conventional contact lenses—to a more proactive, evidence-based approach focused on slowing disease progression,” said Dwight Akerman, OD, MBA, FAAO, Dipl.…EYECAREJul 22 2026
Growth Expectations Rebound for Small Businesses in Second Quarter, Small Business Index IndicatesWASHINGTON, D.C.—During the second quarter of 2026, small business confidence remained stable, as indicated by the most recent Small Business Index (SBI) from the U.S. Chamber of Commerce. The Index hit 66.5 in Q2 2026, remaining virtually unchanged from the previous quarter's score of 67.0, and tracking just above the 65.2 reported at this time…EYECAREJul 22 2026
Healthy Diet Too Expensive for One in Three People Globally, UN Report FindsOne in three people cannot afford to eat a healthy diet, a new report has found, prompting calls for urgent action on food affordability. There are 2.69 billion people unable to afford a diverse diet that meets their energy and nutrient needs, and it will take “immense” amounts of work to achieve the global target…EYECAREJul 22 2026
Measles Cases Set 35-Year U.S. Record With Months to Go in 2026The United States has recorded more measles cases this year than in any year since 1991, with more than five months still left on the calendar. The country had logged 2,295 cases as of Tuesday, according to Johns Hopkins University's U.S. measles tracker. That total edges past the 2,289 cases reported for all of last…EYECAREJul 22 2026
Innovative Eyewear CEO Harrison Gross Speaks to Smart Glasses, Partnerships and Growth in VMAIL ExclusiveMIAMI—We’re little more than halfway through 2026, and Innovative Eyewear (NASDAQ: LUCY; LUCYW), developer and manufacturer of smart eyewear under the Lucyd, Lucyd Armor, Reebok, Eddie Bauer, and Nautica brands, has not wasted any time in making their mark. The company has posted double-digit increases for both year-end 2025 and the first two quarters of…EYECAREJul 22 2026
Kalaris Therapeutics Appoints Liisa Bayko as New Chief Financial OfficerBERKELEY HEIGHTS, N.J.—Kalaris Therapeutics, Inc. (Nasdaq: KLRS), a clinical-stage biopharmaceutical company focused on developing and commercializing treatments for common retinal diseases  has announced the appointment of Liisa Bayko, MBA, as chief financial officer, effective immediately. The company said Bayko’s hire as CFO supports its continued growth as it enrolls its phase 1b/2 study of TH103…EYECAREJul 22 2026
International Opticians Association Spotlights Six Finalists for International Optician of the Year AwardKENT, U.K.—The International Opticians Association (IOA) has announced the full list of nominees for the IOA Silmo International Optician of the Year Award, which is given annually in partnership with Silmo International.EYECAREJul 22 2026
University of Waterloo Researchers Develop 3D-Printed Contacts Made in 20 MinutesWATERLOO, Ontario—The University of Waterloo (UW) has announced a breakthrough combination of new silicone materials and advanced 3D printing technology developed by UW researchers that could transform how contact lenses are manufactured.EYECAREJul 22 2026
Virtual Ophthalmic Surgical Training Showing ‘Measurable Success’ in Global SettingsNEW YORK—Fundamental XR has shared that its successful collaboration with Orbis International to deliver a virtual reality ophthalmic training program across Africa has reported strong momentum and measurable success in the first half of 2026.EYECAREJul 22 2026
At Least 930 People Have Died in Congo's Ebola OutbreakAt least 930 people have died in Congo's Ebola outbreak, the country's Ministry of Health said Monday, with 37 new deaths recorded in a 24-hour span Friday into Saturday, one of the highest totals. The deaths were recorded out of the 2,344 cases confirmed as of Saturday, the health ministry said.EYECAREJul 21 2026
Why Do Some Dementia Patients ‘Return’ Just Before They Die?In the spring of 2000, while completing his degree in psychology at the University of Vienna, Alexander Batthyany received an unusual call from his mother. She had just gotten off the phone with Batthyany’s grandmother. “I do not know what happened—but you should call,” his mother told him. “Somehow, she’s back again.” Batthyany was confused:…EYECAREJul 21 2026
Drugs for Dry AMD Linked to Thickening of Retinal NerveComplement inhibitors to treat geographic atrophy (GA) were associated with thickening of the retinal nerve fiber layer (RNFL), which could be helpful or pathologic, according to a study reported in Montreal. Both FDA-approved complement inhibitors were linked to an increase in the RNFL, whereas untreated GA, or dry age-related macular degeneration (AMD), and anti-VEGF injections…EYECAREJul 21 2026
CooperVision Appoints Brenda Raphael as Vice President of Marketing, AmericasROCHESTER, N.Y.—CooperVision, a division of CooperCompanies (Nasdaq:COO) and a leading manufacturer of contact lenses, has named Brenda Raphael as vice president of marketing, Americas, effective immediately. In this role, Raphael's responsibilities include oversight of U.S. marketing for the company's brand portfolio, customer marketing, and professional affairs, CooperVision stated in the announcement. The company further noted…EYECAREJul 21 2026
EyeMed, OneSight EssilorLuxottica Foundation Join Forces on New Disaster Relief ProgramMASON, Ohio—EyeMed and OneSight EssilorLuxottica Foundation have announced the creation of the EyeMed Cares Disaster Relief Replacement Program, an expansion of their collaboration to now provide a more coordinated approach to supporting eligible EyeMed members.EYECAREJul 21 2026
Deya Partners With Illinois College of Optometry on AI-Model Training ResearchNEW YORK—Deya, a technology startup that aims to help ECPs deliver doctor-controlled tele-eyecare services through a smartphone app, has entered into a sponsorship agreement with the Illinois College of Optometry (ICO) to support a new research project.EYECAREJul 21 2026
Global Summit for Eye Health Adds Bangladesh, Guyana and Nigeria as Co-HostsST. JOHN’S, Antigua and Barbuda, LONDON—The International Agency for the Prevention of Blindness (IAPB) recently announced at the United Nations that the countries of Bangladesh, Guyana and Nigeria will officially serve as co-hosts for the first ever Global Summit for Eye Health.EYECAREJul 21 2026
Taylor Farms Lettuce Sample Produced False Positive for Cyclospora, FDA SaysA Food and Drug Administration test on a sample of lettuce from a supplier that has recalled products because of a multistate cyclosporiasis outbreak produced a false positive for the parasite, the agency said Sunday. The false positive was discovered when the FDA again reviewed the results of a sample from Taylor Farms de Mexico…EYECAREJul 20 2026
How to Keep Babies Safe When Temperatures SoarInfants, toddlers and young children need outdoor activity to build strong bodies and minds, but they also require extra care in the heat. In the summer months, those twin imperatives can make parents anxious. How long should kids be out? How do I know they're OK? What should I avoid?EYECAREJul 20 2026
Vaccine to Prevent Pancreatic Cancer Shows Early PromiseAn off-the-shelf vaccine that targets common KRAS mutations appears safe and generates a durable immune response in people at a high risk for pancreatic cancer, according to a new phase 1 trial. Researchers found that the experimental vaccine spurred KRAS-targeted immune responses in 18 of 20 trial participants, all of whom had a genetic predisposition…EYECAREJul 20 2026
Finalists Named for International Optician of the Year Award, Including Two MIWO AlumnaeKENT, U.K.—The International Opticians Association (IOA) has announced the finalists for its International Optician of the Year Award, given annually in partnership with Silmo International, in recognition of the importance of the optician in the optical business. Among the nominees are two U.S. opticians and Vision Monday Most Influential Women in Optical alumni including Cira…EYECAREJul 20 2026
STAAR Surgical Shows Strong Preliminary Q2 Results, With Double-Digit Sales Growth in AmericasLAKE FOREST, Calif.—STAAR Surgical Company (NASDAQ: STAA) announced strong unaudited preliminary results for the second quarter ended July 3, 2026, with net sales for 2026 expected to exceed $90 million, compared with the $44.3 million recorded in same period of 2025.EYECAREJul 20 2026
l.a.Eyeworks Spotlights Art Matters’ Gai Gherardi Fellowship With Limited-Edition FrameLOS ANGELES—l.a.Eyeworks has announced the release of a limited-edition “Yello” colorway of its Button frame, with proceeds benefitting the Gai Gherardi Fellowship, established by the New York-based non-profit foundation Art Matters in June 2025.EYECAREJul 20 2026
The Rise of Office-Based Surgery Strengthens Ties Between Optometry and OphthalmologyA growing number of ophthalmologists are moving procedures out of hospitals and into fully equipped surgical suites inside the office—a shift that's reshaping how, and where, patients get vision-saving care. The office-based surgery (OBS) model is gaining traction as ophthalmologists turn to performing surgery in an accredited, in-office suite rather than a hospital or ambulatory…EYECAREJul 17 2026
Wildfire Smoke Kills Tens of Thousands of People a Year. Here’s How It Attacks the BodySmoke from wildfires—which are burning more of the Northern Hemisphere as Earth warms—attacks nearly every system in the human body, killing tens of thousands of people a year, numerous medical studies show. It attacks the body immediately, spiking asthma cases with increased ambulance runs within hours, swamps emergency rooms in a day or so with…EYECAREJul 17 2026
Cyclosporiasis Outbreak Traced to Lettuce From Mexico Used by Taco Bell, CDC SaysA lettuce supplier to fast-food giant Taco Bell has been linked to a nationwide cyclosporiasis outbreak that has sickened thousands of people, the Centers for Disease Control and Prevention confirmed Friday. A traceback investigation by the Food and Drug Administration identified a single supplier of iceberg lettuce from Mexico that was used by Taco Bell…EYECAREJul 17 2026
Studies Document Brain Swelling, Sepsis in U.S. Measles OutbreaksAs U.S. measles cases approach last year's record-breaking total, studies on South Carolina and Utah's large outbreaks showed cases of encephalitis and sepsis among the hospitalized patients. In both states, hypoxemia and pneumonia were the most common conditions leading to hospitalization for measles, with some admissions driven by electrolyte abnormalities, sepsis and shock.EYECAREJul 17 2026
Newton CEO Davis Corley Talks Strategy and Growth in VMAIL ExclusiveDALLAS—Late last summer, Neurolens, a leading lens technology company known for providing solutions to digital eye strain, headaches, neck pain and vision health issues, announced an official rebrand to Newton. Named after Sir Isaac Newton, the company said at the time that the transformation reflected its commitment to challenging conventional standards in optometry and pioneering…EYECAREJul 17 2026
American Optometric Association Celebrates 2026 Leadership Institute GraduatesALEXANDRIA, Va.—The American Optometric Association's (AOA) Leadership Institute has announced its 2026 graduating class, which was recognized at Optometry's Meeting held June 17-20, 2026, in Phoenix, Ariz.EYECAREJul 17 2026
Women In Optometry’s Leadership Conference Keynote to Highlight Importance of Confidence and AuthenticityNEWARK, N.J.—Women In Optometry (WO) will host its 8th annual Women’s Leadership Conference on Tuesday, September 29, 2026, from 4:00-6:45 p.m., during the 2026 American Academy of Optometry (AAO) Annual Meeting in Anaheim, Calif.EYECAREJul 17 2026
Researchers Find Small Increased Risk of Sudden Vision Loss Associated With GLP-1 MedicationsA medication commonly used to treat Type 2 diabetes and obesity was associated with a slight increase in risk for a rare condition involving reduced blood flow to the optic nerve that can cause sudden vision loss, according to Rutgers researchers. Their study, published in Annals of Internal Medicine, examined data from a large database…EYECAREJul 16 2026
Taking Painkillers Before Flu Shot Doesn’t Lower Its Effectiveness, Study FindsAfter receiving the flu vaccine, people sometimes experience achy muscles, fever, headaches, and pain at the injection site. To avoid that discomfort, some might take acetaminophen (Tylenol) or nonsteroidal anti-inflammatory drugs (NSAIDs) before getting their vaccine. Yet few studies have examined if taking analgesics before receiving a flu shot might affect one’s immune response or…EYECAREJul 16 2026
Infections May Raise Long-Term Risk for Chronic DiseaseThe consequences of infectious diseases extend beyond the acute phase of the illness: Influenza, COVID, pneumonia, and other such illnesses are not only acutely dangerous but also can cast a long shadow over one’s health—from metabolic diseases such as diabetes to an increased risk for heart attacks, emphasized Leif Erik Sander, MD, medical director, Department…EYECAREJul 16 2026
RxSight Tags Aziz Mottiwala as President and CEO, Ron Kurtz, MD, as CMOALISO VIEJO, Calif.—RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company focused on providing high-quality customized vision to patients after cataract surgery, has announced a planned leadership transition with the appointment of Aziz Mottiwala as president and chief executive officer, succeeding Ron Kurtz, MD, who will continue to serve the company in the role of…EYECAREJul 16 2026
Johnson & Johnson Reports Strong Q2, Solid Growth in Vision CareNEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ), a global healthcare company, announced its second-quarter 2026 financial results yesterday, reporting a 6.6 percent increase in sales to $25.3 billion. The company achieved 5.6 percent operational growth and 5.7 percent adjusted operational growth. Within the MedTech segment, which saw revenue rise 4.5 percent to $8.9 billion, the…EYECAREJul 16 2026
American Academy of Optometry Announces 2026 Award RecipientsWINTER PARK, Fla.—The American Academy of Optometry (AAO) has announced its 2026 award recipients, continuing its annual tradition of recognizing distinguished individuals who have made countless important contributions to advancing the profession of optometry.EYECAREJul 16 2026
SUNY Optometry Strengthens Research Enterprise With Arrival of Two Leading Vision ScientistsNEW YORK—SUNY College of Optometry has announced that it is strengthening its research activity with the appointment of two vision scientists whose work will expand the college’s expertise in areas of patient care, public health and the future of vision science.EYECAREJul 16 2026
Spectacles with non‑refractive opaque features for paediatric myopia: a safety pilot trial Eye, Published online: 14 August 2026; doi:10.1038/s41433-026-04795-5Spectacles with non‑refractive opaque features for paediatric myopia: a safety pilot trialEyeAug 14 2026
Transition from intermediate to late AMD and associated changes in vision by two years in a multicentre cohort study in Europe- INTERCEPT-AMD Report 3 Eye, Published online: 13 August 2026; doi:10.1038/s41433-026-04759-9Transition from intermediate to late AMD and associated changes in vision by two years in a multicentre cohort study in Europe- INTERCEPT-AMD Report 3EyeAug 13 2026
Dual ocular circulatory compromise: central retinal artery occlusion and choroidal infarction Eye, Published online: 13 August 2026; doi:10.1038/s41433-026-04805-6Dual ocular circulatory compromise: central retinal artery occlusion and choroidal infarctionEyeAug 13 2026
Timing of corticosteroid-sparing therapies in non-infectious uveitis: a population-based cohort study from DenmarkEye, Published online: 11 August 2026; doi:10.1038/s41433-026-04728-2Timing of corticosteroid-sparing therapies in non-infectious uveitis: a population-based cohort study from DenmarkEyeAug 11 2026
Incidence and risk factors for retinopathy of prematurity: A hospital-based study in IranEye, Published online: 11 August 2026; doi:10.1038/s41433-026-04804-7Incidence and risk factors for retinopathy of prematurity: A hospital-based study in IranEyeAug 11 2026
The fox-tail sign: perineural spread of adenoid cystic carcinomaEye, Published online: 11 August 2026; doi:10.1038/s41433-026-04788-4The fox-tail sign: perineural spread of adenoid cystic carcinomaEyeAug 11 2026
Correction: Vision-related quality of life in non-neovascular age-related macular degeneration: a protocol for systematic review and meta-analysisEye, Published online: 10 August 2026; doi:10.1038/s41433-026-04787-5Correction: Vision-related quality of life in non-neovascular age-related macular degeneration: a protocol for systematic review and meta-analysisEyeAug 10 2026
Emboss imaging revealing the characteristic ‘bag of worms’ appearance in retinal racemose haemangiomaEye, Published online: 10 August 2026; doi:10.1038/s41433-026-04800-xEmboss imaging revealing the characteristic ‘bag of worms’ appearance in retinal racemose haemangiomaEyeAug 10 2026
Localised lenticular hydrodissection due to iatrogenic needle injury: OCT to the rescueEye, Published online: 10 August 2026; doi:10.1038/s41433-026-04802-9Localised lenticular hydrodissection due to iatrogenic needle injury: OCT to the rescueEyeAug 10 2026
Multimodal imaging of pigmented paravenous retinochoroidal atrophyEye, Published online: 10 August 2026; doi:10.1038/s41433-026-04797-3Multimodal imaging of pigmented paravenous retinochoroidal atrophyEyeAug 10 2026
Exploring the mixed marketing authorisation pathway: a case study in ophthalmologyEye, Published online: 08 August 2026; doi:10.1038/s41433-026-04792-8Exploring the mixed marketing authorisation pathway: a case study in ophthalmologyEyeAug 08 2026
Aflibercept 8 mg in neovascular age-related macular degeneration and diabetic macular oedema: Translating clinical trials into clinical practiceEye, Published online: 07 August 2026; doi:10.1038/s41433-026-04779-5Aflibercept 8 mg in neovascular age-related macular degeneration and diabetic macular oedema: Translating clinical trials into clinical practiceEyeAug 07 2026
Ophthalmic and psychiatric health: the overlooked connection between ocular diseases and mental disordersEye, Published online: 07 August 2026; doi:10.1038/s41433-026-04780-yOphthalmic and psychiatric health: the overlooked connection between ocular diseases and mental disordersEyeAug 07 2026
Infographic: Efficacy and safety of high-dose intravitreal aflibercept 8 mg in patients with diabetic macular oedema: week 96 results from the phase 2/3 PHOTON trialEye, Published online: 07 August 2026; doi:10.1038/s41433-026-04597-9Infographic: Efficacy and safety of high-dose intravitreal aflibercept 8 mg in patients with diabetic macular oedema: week 96 results from the phase 2/3 PHOTON trialEyeAug 07 2026
Photic retinal injury: Time to move beyond case reports—A PRISM Study Group perspectiveEye, Published online: 07 August 2026; doi:10.1038/s41433-026-04778-6Photic retinal injury: Time to move beyond case reports—A PRISM Study Group perspectiveEyeAug 07 2026
Can large language models accurately triage oculoplastic referrals?Eye, Published online: 07 August 2026; doi:10.1038/s41433-026-04766-wCan large language models accurately triage oculoplastic referrals?EyeAug 07 2026
Persistent fluid, persistent risk: predicting pachychoroid macular atrophy in chronic central serous chorioretinopathyEye, Published online: 06 August 2026; doi:10.1038/s41433-026-04793-7Persistent fluid, persistent risk: predicting pachychoroid macular atrophy in chronic central serous chorioretinopathyEyeAug 06 2026
Comment on: ‘Patient experience of and barriers to the eye examination’Eye, Published online: 06 August 2026; doi:10.1038/s41433-026-04791-9Comment on: ‘Patient experience of and barriers to the eye examination’EyeAug 06 2026
Rethinking intraocular pressure: What does tonometry actually measure?Eye, Published online: 06 August 2026; doi:10.1038/s41433-026-04794-6Rethinking intraocular pressure: What does tonometry actually measure?EyeAug 06 2026
Ocular surface and meibomian gland changes following repeated exposure to 5% povidone-iodine during intravitreal injectionsEye, Published online: 05 August 2026; doi:10.1038/s41433-026-04798-2Ocular surface and meibomian gland changes following repeated exposure to 5% povidone-iodine during intravitreal injectionsEyeAug 05 2026
Nd:YAG laser membranolysis of a fibrin membrane occluding an AADI-250 tubeEye, Published online: 05 August 2026; doi:10.1038/s41433-026-04783-9Nd:YAG laser membranolysis of a fibrin membrane occluding an AADI-250 tubeEyeAug 05 2026
The cataract that wasn’t: aphakic posterior capsular fibrosis with anterior chamber silicone oilEye, Published online: 05 August 2026; doi:10.1038/s41433-026-04785-7The cataract that wasn’t: aphakic posterior capsular fibrosis with anterior chamber silicone oilEyeAug 05 2026
Artificial intelligence is here to stay: the role of scientific etiquetteEye, Published online: 05 August 2026; doi:10.1038/s41433-026-04801-wArtificial intelligence is here to stay: the role of scientific etiquetteEyeAug 05 2026
Infographic: a randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patientsEye, Published online: 05 August 2026; doi:10.1038/s41433-026-04803-8Infographic: a randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patientsEyeAug 05 2026
Multimodal imaging of Yasunari nodules in neurofibromatosis type 1Eye, Published online: 05 August 2026; doi:10.1038/s41433-026-04799-1Multimodal imaging of Yasunari nodules in neurofibromatosis type 1EyeAug 05 2026
Eclipse of the pupil: a giant post-traumatic epithelial implantation cyst of the irisEye, Published online: 04 August 2026; doi:10.1038/s41433-026-04786-6Eclipse of the pupil: a giant post-traumatic epithelial implantation cyst of the irisEyeAug 04 2026
A Choroidal Tide: Amitriptyline-induced Uveal Effusion with a Stellate Oedematous DiscEye, Published online: 04 August 2026; doi:10.1038/s41433-026-04782-wA Choroidal Tide: Amitriptyline-induced Uveal Effusion with a Stellate Oedematous DiscEyeAug 04 2026
Response to: ‘Comment on: ‘Patient experience of and barriers to the eye examination”Eye, Published online: 04 August 2026; doi:10.1038/s41433-026-04790-wResponse to: ‘Comment on: ‘Patient experience of and barriers to the eye examination”EyeAug 04 2026
Relative preservation of the outer retinal layers despite inner retinal thinning in migraine without auraEye, Published online: 03 August 2026; doi:10.1038/s41433-026-04789-3Relative preservation of the outer retinal layers despite inner retinal thinning in migraine without auraEyeAug 03 2026
The ‘archipelago’ pattern: multilobulated retinal pigment epithelium atrophy in Sorsby macular dystrophyEye, Published online: 03 August 2026; doi:10.1038/s41433-026-04784-8The ‘archipelago’ pattern: multilobulated retinal pigment epithelium atrophy in Sorsby macular dystrophyEyeAug 03 2026
Large-scale analysis of risk factors for developing retinal vein occlusion in the fellow eyeEye, Published online: 03 August 2026; doi:10.1038/s41433-026-04717-5Large-scale analysis of risk factors for developing retinal vein occlusion in the fellow eyeEyeAug 03 2026
Endophthalmitis rates after macular hole and epiretinal membrane surgery: a multicentre TriNetX studyEye, Published online: 03 August 2026; doi:10.1038/s41433-026-04700-0Endophthalmitis rates after macular hole and epiretinal membrane surgery: a multicentre TriNetX studyEyeAug 03 2026
Perforating scleral vessel angular metrics as a structural biomarker of myopic choroidal neovascularisationEye, Published online: 01 August 2026; doi:10.1038/s41433-026-04781-xPerforating scleral vessel angular metrics as a structural biomarker of myopic choroidal neovascularisationEyeAug 01 2026
Nasolacrimal duct obstruction following allo-HSCT: an overlooked manifestation of ocular graft-versus-host diseaseEye, Published online: 01 August 2026; doi:10.1038/s41433-026-04776-8Nasolacrimal duct obstruction following allo-HSCT: an overlooked manifestation of ocular graft-versus-host diseaseEyeAug 01 2026
Comment on: ‘Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort study’Eye, Published online: 31 July 2026; doi:10.1038/s41433-026-04378-4Comment on: ‘Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort study’EyeJul 31 2026
Barriers to access to ophthalmology services in Latin America: A Scoping reviewEye, Published online: 30 July 2026; doi:10.1038/s41433-026-04761-1Barriers to access to ophthalmology services in Latin America: A Scoping reviewEyeJul 30 2026
Photobiomodulation therapy for children’s eye and vision conditionsEye, Published online: 29 July 2026; doi:10.1038/s41433-026-04757-xPhotobiomodulation therapy for children’s eye and vision conditionsEyeJul 29 2026
Intrastromal silicone oil as symptomatic treatment of painful bullous keratopathy: a case seriesEye, Published online: 29 July 2026; doi:10.1038/s41433-026-04772-yIntrastromal silicone oil as symptomatic treatment of painful bullous keratopathy: a case seriesEyeJul 29 2026
Iris metastasis from hepatocellular carcinomaEye, Published online: 28 July 2026; doi:10.1038/s41433-026-04777-7Iris metastasis from hepatocellular carcinomaEyeJul 28 2026
Application of platelet-rich fibrin membrane versus amniotic membrane graft transplantation after pterygium excision: a randomised clinical trialEye, Published online: 28 July 2026; doi:10.1038/s41433-026-04773-xApplication of platelet-rich fibrin membrane versus amniotic membrane graft transplantation after pterygium excision: a randomised clinical trialEyeJul 28 2026
The evolution of pre-descemet endothelial keratoplasty (PDEK)Eye, Published online: 28 July 2026; doi:10.1038/s41433-026-04655-2The evolution of pre-descemet endothelial keratoplasty (PDEK)EyeJul 28 2026
Massive suprachoroidal haemorrhage in a patient with neovascular age-related macular degenerationEye, Published online: 27 July 2026; doi:10.1038/s41433-026-04774-wMassive suprachoroidal haemorrhage in a patient with neovascular age-related macular degenerationEyeJul 27 2026
Photoreceptor replacement: a disease-agnostic approach for the treatment of advanced retinal degenerationEye, Published online: 25 July 2026; doi:10.1038/s41433-026-04742-4Photoreceptor replacement: a disease-agnostic approach for the treatment of advanced retinal degenerationEyeJul 25 2026
Generative adversarial networks (GAN) for pre-dilation retinal photograph quality enhancementEye, Published online: 24 July 2026; doi:10.1038/s41433-026-04767-9Generative adversarial networks (GAN) for pre-dilation retinal photograph quality enhancementEyeJul 24 2026
Square lens and cataract in a child with a de novo <i>MAF</i> gene mutationEye, Published online: 24 July 2026; doi:10.1038/s41433-026-04764-ySquare lens and cataract in a child with a de novo MAF gene mutationEyeJul 24 2026
Short-term efficacy and safety of transcleral lutein iontophoresis in patients with intermediate amd and reticular pseudodrusen: A retrospective studyEye, Published online: 24 July 2026; doi:10.1038/s41433-026-04731-7Short-term efficacy and safety of transcleral lutein iontophoresis in patients with intermediate amd and reticular pseudodrusen: A retrospective studyEyeJul 24 2026
Association of accelerometer-monitored physical activity with incident cataract: epidemiological and genetic evidenceEye, Published online: 23 July 2026; doi:10.1038/s41433-026-04727-3Association of accelerometer-monitored physical activity with incident cataract: epidemiological and genetic evidenceEyeJul 23 2026
Correction: I-SCREEN: Development of an AI-based infrastructure for community-wide screening and prediction of progression in age-related macular degeneration providing accessible shared careEye, Published online: 23 July 2026; doi:10.1038/s41433-026-04771-zCorrection: I-SCREEN: Development of an AI-based infrastructure for community-wide screening and prediction of progression in age-related macular degeneration providing accessible shared careEyeJul 23 2026
Distinguishing congenital pupillary membranesEye, Published online: 23 July 2026; doi:10.1038/s41433-026-04741-5Distinguishing congenital pupillary membranesEyeJul 23 2026
Asymmetry pigmented paravenous retinochoroidal atrophy with unilateral macular staphylomaEye, Published online: 23 July 2026; doi:10.1038/s41433-026-04724-6Asymmetry pigmented paravenous retinochoroidal atrophy with unilateral macular staphylomaEyeJul 23 2026
Corneal papilloma obscuring the entire corneaEye, Published online: 23 July 2026; doi:10.1038/s41433-026-04770-0Corneal papilloma obscuring the entire corneaEyeJul 23 2026
Clinically aligned artificial intelligence for glaucoma diagnosis: enhancing retinal nerve fibre layer interpretation from fundus imagesEye, Published online: 23 July 2026; doi:10.1038/s41433-026-04758-wClinically aligned artificial intelligence for glaucoma diagnosis: enhancing retinal nerve fibre layer interpretation from fundus imagesEyeJul 23 2026
Outcomes of phacoemulsification combined with ab interno trabeculotomy: stratified by incision extent, glaucoma severity, and baseline number of medicationsEye, Published online: 22 July 2026; doi:10.1038/s41433-026-04749-xOutcomes of phacoemulsification combined with ab interno trabeculotomy: stratified by incision extent, glaucoma severity, and baseline number of medicationsEyeJul 22 2026
Foundation model-based haemoglobin concentration estimation and anaemia risk assessment from retinal fundus imagesEye, Published online: 22 July 2026; doi:10.1038/s41433-026-04743-3Foundation model-based haemoglobin concentration estimation and anaemia risk assessment from retinal fundus imagesEyeJul 22 2026
A novel method for evaluating the thickness and keratometry profiles of toric lenticules created by a new-generation keratorefractive lenticule extraction platformEye, Published online: 22 July 2026; doi:10.1038/s41433-026-04769-7A novel method for evaluating the thickness and keratometry profiles of toric lenticules created by a new-generation keratorefractive lenticule extraction platformEyeJul 22 2026
Correction: The role of feedback in amblyopia treatment – a multi-centre randomised control trialEye, Published online: 21 July 2026; doi:10.1038/s41433-026-04508-yCorrection: The role of feedback in amblyopia treatment – a multi-centre randomised control trialEyeJul 21 2026
Lifetime incidence of low vision and blindness from glaucoma in a large public ophthalmology department: a retrospective cohort studyEye, Published online: 20 July 2026; doi:10.1038/s41433-026-04660-5Lifetime incidence of low vision and blindness from glaucoma in a large public ophthalmology department: a retrospective cohort studyEyeJul 20 2026
Hyperreflective foci and subretinal drusenoid deposits as predictors of exudation in intermediate AMD eyes with contralateral neovascular AMDEye, Published online: 18 July 2026; doi:10.1038/s41433-026-04617-8Hyperreflective foci and subretinal drusenoid deposits as predictors of exudation in intermediate AMD eyes with contralateral neovascular AMDEyeJul 18 2026
Azithromycin versus azithromycin-pyrimethamine and sulfadiazine-pyrimethamine for the treatment of ocular toxoplasmosis: a retrospective comparative case-seriesEye, Published online: 17 July 2026; doi:10.1038/s41433-026-04685-wAzithromycin versus azithromycin-pyrimethamine and sulfadiazine-pyrimethamine for the treatment of ocular toxoplasmosis: a retrospective comparative case-seriesEyeJul 17 2026
A tick too close: peripunctal ocular tick infestation and the importance of punctal assessmentEye, Published online: 17 July 2026; doi:10.1038/s41433-026-04733-5A tick too close: peripunctal ocular tick infestation and the importance of punctal assessmentEyeJul 17 2026
Rizzuti sign: an easily overlooked indicator of advanced keratoconusEye, Published online: 17 July 2026; doi:10.1038/s41433-026-04756-yRizzuti sign: an easily overlooked indicator of advanced keratoconusEyeJul 17 2026
Embryodysgenesis of the Lids and OrbitEye, Published online: 17 July 2026; doi:10.1038/s41433-026-04740-6Embryodysgenesis of the Lids and OrbitEyeJul 17 2026
Ghost in the Machine: The Medicolegal Implications of AI-Generated Clinical CorrespondenceEye, Published online: 16 July 2026; doi:10.1038/s41433-026-04755-zGhost in the Machine: The Medicolegal Implications of AI-Generated Clinical CorrespondenceEyeJul 16 2026
Use of Fellow Eyes as Controls in Clinical Trials To the Editor Von der Emde et al recently thoroughly assessed the correlation between eyes in enlargement rates of geographic atrophy (GA) in the Age-Related Eye Disease Study 2 (AREDS2) and found lower correlation than identified in previous studies. They advised, “Researchers should be cautious of trials and analyses relying on assumptions of highly correlated…JAMA Ophthalmology Online FirstAug 13 2026
Standardizing Conservative Treatment for Congenital Nasolacrimal Duct Obstruction Congenital nasolacrimal duct obstruction (CNLDO) is one of the most common disorders encountered during infancy. Although spontaneous resolution is well recognized, clinicians must balance the potential benefits of conservative management against office probing to achieve more rapid symptom resolution. Zheng and colleagues report the first randomized comparison of massage vs immediate probing for infants with…JAMA Ophthalmology Online FirstAug 13 2026
Progression of Pachychoroid Disease—Who Is At Risk? Pachychoroid disease refers to a spectrum of disorders characterized by choroidal vascular remodeling, including dilated outer Haller vessels (pachyvessels), attenuation of the choriocapillaris and Sattler layer, choroidal vascular hyperpermeability, and increased choroidal thickness in many—but not all—eyes. Although its pathogenesis remains incompletely understood, accumulating evidence implicates impaired choroidal venous outflow and venous overload as key…JAMA Ophthalmology Online FirstAug 13 2026
Iris Nodule and Pulmonary Sarcoidosis in a Patient Aged 57 Years This case report describes a woman aged 57 years who presented with a 3-month history of cough and dyspnea, during which a solitary iris nodule was discovered on ophthalmologic consultation and led to a diagnosis of pulmonary sarcoidosis.JAMA Ophthalmology Online FirstAug 13 2026
Sudden-Onset Ptosis in a Young Female Patient A 25-year-old female patient with a recent history of left-sided root canal, tooth extraction, and bone graft presented with left eye pain and blurry vision, ptosis, persistent headache, and neck stiffness. Examination revealed left mydriasis without relative afferent pupillary defect. What would you do next?JAMA Ophthalmology Online FirstAug 13 2026
Lacrimal Sac Massage vs Probing for Congenital Nasolacrimal Duct Obstruction This noninferiority randomized trial evaluates the noninferiority of lacrimal sac massage compared to lacrimal duct probing for congenital nasolacrimal duct obstruction in infants.JAMA Ophthalmology Online FirstAug 13 2026
Time-Varying Effects of Valacyclovir Prophylaxis in the Zoster Eye Disease Study This post hoc exploratory analysis of the ZEDS randomized clinical trial assesses temporal patterns of potential benefit of suppressive valacyclovir treatment to reduce risk of new or worsening stromal keratitis, endothelial keratitis, iritis, or dendriform epithelial keratitis.JAMA Ophthalmology Online FirstAug 13 2026
Use of Fellow Eyes as Controls in Clinical Trials—Reply In Reply We thank Maguire for her thoughtful letter and agree with the central distinction she emphasizes. Low correlation in geographic atrophy (GA) enlargement rates between fellow eyes would not, by itself, invalidate a fellow-eye comparison in a randomized clinical trial. Our conclusion was even more specific, and we reiterate, researchers should be cautious of…JAMA Ophthalmology Online FirstAug 13 2026
Incidence and Risk Factors for Progression of Pachychoroid Subtype This multicenter cohort study evaluates progression, diagnostic transitions, and associated risk factors in eyes with pachychoroid subtype.JAMA Ophthalmology Online FirstAug 13 2026
Standardization of Retinal Vasculitis TerminologyThis Delphi consensus study investigates if standardized consensus-based definitions are associated with an improvement in the terminology and classification of retinal vasculitis and related retinal vascular inflammatory conditions.JAMA Ophthalmology Online FirstAug 06 2026
A Funder’s Perspective—ReplyIn Reply We thank Hofland for his correspondence on this topic. Nonprofit funders have indeed been important partners in our field’s artificial intelligence (AI) journey. Research to Prevent Blindness’ first funding of individual grants in AI was in 2018, which preceded the current explosion in interest in AI due to large language models and showed…JAMA Ophthalmology Online FirstAug 06 2026
A Funder’s PerspectiveTo the Editor In response to Liu’s Viewpoint article, “Funders’ Role in Ophthalmic Artificial Intelligence Innovations,” I would like to provide a funder’s perspective, specifically from Research to Prevent Blindness (RPB), a large, if not the largest, nonprofit funder of vision research across all sight-threatening conditions. Liu mentioned that it is difficult to assess the…JAMA Ophthalmology Online FirstAug 06 2026
Candy-Stripe Sign in Ghost Cell GlaucomaThis case report discusses the classic appearance of ghost cell glaucoma in the anterior chamber of a male patient aged 65 years who presented with pain, redness, and decreased visual acuity in his left eye for 1 week.JAMA Ophthalmology Online FirstAug 06 2026
Progressive Asymmetric Bilateral Violaceous Periorbital EdemaA 66-year-old man had worsening bilateral periorbital erythema and edema for 1 month, greater on the right side. Examination showed 20/40 visual acuity with glasses in each eye, otherwise normal ocular findings, and right-sided induration and violaceous discoloration extending from the forehead to the cheek and involving both eyelids. What is your diagnosis?JAMA Ophthalmology Online FirstAug 06 2026
Risk of Pseudophakic Cystoid Macular Edema in Eyes With Previous Pars Plana VitrectomyThis cohort study evaluates associations between prior pars plana vitrectomy and incidence of cystoid macular edema after cataract surgery.JAMA Ophthalmology Online FirstJul 30 2026
Gonioscopy-Assisted Transluminal Trabeculotomy Using RetroilluminationThis case report discusses a transscleral retroillumination technique to better distinguish the trabecular meshwork during gonioscopy-assisted transluminal trabeculotomy.JAMA Ophthalmology Online FirstJul 30 2026
XXYLT1 and Mendelian Retinal DystrophyThis genome-wide association study evaluates genes associated with retinal dystrophy.JAMA Ophthalmology Online FirstJul 30 2026
Trends in Hockey-Related Ocular TraumaThis cross-sectional study evaluates trends in hockey-related ocular trauma in the US.JAMA Ophthalmology Online FirstJul 23 2026
RAFT-OS Transplant for Aniridia-Related KeratopathyThis nonrandomized clinical trial evaluates the safety, feasibility, and clinical outcomes of RAFT-OS, a tissue-engineered collagen scaffold incorporating allogeneic limbal epithelial stem cells and stromal keratocytes, in adults with advanced aniridia-related keratopathy.JAMA Ophthalmology Online FirstJul 23 2026
Methodological Bias in Glaucoma IOP Management—ReplyIn Reply We thank Haque and Hoque for their interest in our recently published study and thoughtful comments regarding our methodological decisions.JAMA Ophthalmology Online FirstJul 23 2026
Subretinal Fluid After Repeated Low-Level Red Light TherapyThis case report describes an 11-year-old boy who developed unilateral subretinal fluid, choroidal thickening, and mild vision loss after prolonged repeated low-level red light therapy for myopia control, with partial improvement after discontinuing treatment.JAMA Ophthalmology Online FirstJul 23 2026
Methodological Bias in Glaucoma IOP ManagementTo the Editor We read with interest the study by Polski et al regarding the influence of intraocular pressure (IOP) on clinical decision-making. While the authors present a relatively robust dataset, we suggest that specific methodological definitions regarding IOP selection and treatment escalation may have inadvertently introduced artifacts that mimic the appearance of a heuristic…JAMA Ophthalmology Online FirstJul 23 2026
Bilateral Sectoral Iris Heterochromia and Hirschsprung Disease in a 5-Year-Old ChildThis case report describes bilateral sectoral iris heterochromia in a boy aged 5 years with a history of intestinal obstruction 5 days after birth and a diagnosis of Hirschsprung disease.JAMA Ophthalmology Online FirstJul 23 2026
Error in MethodsThe Original Investigation titled “Influence of Intraocular Pressure on Clinical Decision-Making in Glaucoma Management,” published on January 8, 2026, was corrected to fix an incorrect description in the Study Design section of the Methods; the correct description of medical treatment escalation is “a new prescription order for a type of IOP-lowering medication not previously prescribed.”…JAMA Ophthalmology Online FirstJul 23 2026
Global Axial Length Centile ChartsThis pooled cohort study draws on data from the CREAM-Kids Consortium to generate global axial length centile charts for children and adolescents by sex and region.JAMA Ophthalmology Online FirstJul 16 2026
Axial Length and the Future of Myopia Risk StratificationThe global escalation of myopia has shifted our focus from refractive correction to disease modification, with axial length (AL) being increasingly recognized as a central biomarker linking excessive pediatric ocular growth to lifelong risk of visual impairment from pathologic structural changes. In this issue of JAMA Ophthalmology, Kneepkens and colleagues provide new insights regarding region-…JAMA Ophthalmology Online FirstJul 16 2026
Migrating Embolus in a Case of Transient Branch Retinal Artery OcclusionThis case report visually describes the course of an embolus after dislodgement through the retinal vasculature of a female patient aged 55 years who experienced a transient branch retinal artery occlusion.JAMA Ophthalmology Online FirstJul 16 2026
Factors Associated With Progression to Primary Angle ClosureThis post hoc analysis of a randomized clinical trial examines data for trial participants who had imaging to determine which baseline anterior segment parameters are associated with progression from primary angle closure suspect to primary angle closure.JAMA Ophthalmology Online FirstJul 16 2026

© ECM All rights reserved 2026.